Dark

SNGX
Soligenix, Inc. Common Stock
stock NASDAQ

At Close

Dec 26, 2025 3:59:59 PM EST

1.38USD-3.819%(-0.06)227,971

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 26, 2025 9:17:30 AM EST

1.40USD-2.778%(-0.04)6,464

After-hours

Dec 26, 2025 4:28:30 PM EST

1.37USD-1.083%(-0.01)1,300

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

13.97M

CEO

Christopher Schaber

Headquarters

Princeton, New Jersey, USA

Industry

Biotechnology

Last Split

Jun 6, 20241for16reverse

ATHX JNJ PFE SNY EBS TEVA CBLI XLV

SNGX Stats

Avg. Vol. 10 Day

586,480

Avg. Vol. 30 Day

399,576

Employees

Market Cap

13,969,290

Shares Out.

10,086,130

On/Off Exchange

36%/64%

6 Month Beta

1.64

1 Year Beta

0.88

2 Year Beta

0.77

3 Year Beta

0.58

52 Week Low

1.09

52 Week High

6.23

SMA50

1.48

SMA200

1.93

1 Week

+4.14%

1 Month

-12.89%

3 Month

+24.78%

6 Month

+1.84%

1 Year

-52.08%

2 Year

-87.34%

5 Year

-99.56%

Profile

soligenix, inc. is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous t-cell lymphoma, oral mucositis, pediatric crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.

SNGX Stock Summary

Soligenix, Inc. Common Stock (NASDAQ:SNGX) stock price today is $1.38, and today's volume is 227,971. SNGX is down -3.819% today. The 30 day average volume is 399,576. SNGX market cap is 13.97M with 10,086,130 shares outstanding.